ConocoPhillips, Citigroup and Mattress Firm stumble

Bank stocks continued to tumble as bond prices fell, reducing the interest rates banks can charge on loans.

The company reported positive results from a study of its most advanced drug, a potential treatment for sickle cell disease.

The chemicals maker agreed to be acquired by ethylene producer Westlake Chemical for $33 per share, or $2.33 billion.